Company Active LTD

Company profile

Qure.Ai Technologies Limited

Qure.Ai Technologies Limited is a UK company with status active founded in 2021.

CRN
13309971
Founded
2021
Age
5

Overview

Legal name
QURE.AI TECHNOLOGIES LIMITED
Region
Unknown
Registered address
C/O ROEDL LEGAL LIMITED
170 EDMUND STREET
BIRMINGHAM
UNITED KINGDOM
B3 2HB
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

7 events
09 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

08 Jun
2026

Accounts With Accounts Type Small

Accounts PDF pending

AA | Transaction MzUyNTQwOTk1N2FkaXF6a2N4 | Paper/PDF filed

Published 08 Jun 2026 23:00

26 Mar
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUxMjc4NDc1MmFkaXF6a2N4

Published 26 Mar 2026 14:28

26 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

01 Apr
2021

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2024
Funded years
2024
Age at first award
2 years

Projects

2024 Collaborative R&D

Accelerating trustworthy AI in radiology: scalable software for clinical users to independently validate commercial products at local sites

1 Apr 2024 to 31 Mar 2025

Awarded
£103,551
Total cost £172,585

In this collaborative proposal, the Aival Analysis Lab will be used to evaluate commercial radiology AI products on imaging data representative of a broad Scottish population. We will consider two clinical treatment pathways in line with NHS Scotland service and procurement priorities: stroke triage and urgent suspicion of lung cancer triage, assessing at...

2024 Collaborative R&D

Federated AI Monitoring Service (FAMOS)

1 Feb 2024 to 31 Jan 2025

Awarded
£30,113
Total cost £50,189

This project aims to accelerate the integration of AI in healthcare by developing a privacy-preserving Federated AI Monitoring Service (FAMOS) on top of an existing medical AI platform. Current monitoring and evaluation costs hinder small to medium-sized enterprises (SMEs) from proving the efficacy and safety of their healthcare AI products, impeding adop...

2024 Collaborative R&D

Developing tools for pre-market evaluation and post-market surveillance of Medical Imaging AI

1 Jan 2024 to 31 Dec 2024

Awarded
£103,981
Total cost £173,302

AI tools have shown promise in being able to analyse medical imaging and aid healthcare professionals with their image interpretation speed and accuracy. However, the uptake of these algorithms by healthcare organisations has been slow for several reasons including: ● Lack of independent clinical testing about the accuracy of the algorithms. ● Lack of tra...

Product types

Collaborative R&D